--(BUSINESS WIRE)--Digilab BioVisioN is a 100 % subsidiary of the Boston based Digilab, Inc. Digilab BioVisioN works with companies from the pharmaceutical and diagnostics sectors, analytical instrumentation hardware and software, consumables suppliers, academic institutions and government agencies. Digilab BioVisioN is using its internationally patented Peptidomics® technology platform to offer products and services for biomarker R&D. Besides pre-analytical products and services for specimen generation, peptide enrichment, protein depletion and MALDI mass spectrometry Digilab BioVisioN also offers full biomarker discovery projects for the life science industry under its brand Digilab Peptidomics®.
